First-of-a-kind stem cell therapies set for approval in Japan
Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.
Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.
Andrew Robinson reviews five of the best science picks.
The use of artificial intelligence in the clinic to image slides of cells enables the rapid assessment of cellular characteristics that might help with diagnostic decisions.